Bridge4bio Helps Life Science Companies Achieve Business Growth Globally

March 15, 2010 - PRLog -- Bridge4Bio’s extensive knowledge of the global life sciences and biotechnology sectors plus its high quality business connections across the globe means that its clients often see profitable results more quickly than they dared believe possible.



Bridge4Bio prides itself on the excellence of its client support irrespective of the size or maturity of client’s business.  Swiss-based Xenometrix AG, which is a mutagenicity and cytotoxicity test systems producer, can vouch for the benefits of this client focused approach.



Founded in1995 by Nicole Weiland-Jäggi, PhD and Christian Hodel, MD and Pharmacologist, Xenometrix produces high quality, efficient mutagenicity and cytotoxicity test systems for the use in molecular pharmacology, early stages of drug discovery, screening of chemical, cosmetic, alimentary or agrochemical compounds and for testing environmental water, soil, air or effluents.



“Bridge4Bio has a well established worldwide network in the field of life science and Xenometrix AG is looking for distributors of Xenometrix products worldwide,” explained Nicole Weiland-Jäggi, Xenometrix’s CEO.  “Consequently, the win-win situation is that Xenometrix is profiting from the many worldwide relationships Bridge4Bio has developed.  At the same time

Bridge4Bio profits from the increasing turnover of Xenometrix.  Bridge4Bio is analyzing well the situation of the marketed product and its sales possibilities in existing and new markets and Bridge4Bio has a troubleshooting mentality that I like very much”.



Weiland-Jäggi continued: “Bridge4Bio works very professionally.  The company is reliable and well experienced in the life science market. We enjoy and appreciate the collaboration with Bridge4Bio.  We also consulted them on various different ways to increase the Xenometrix sales”.



“The Bridge4Bio service has saved us time,” admitted Weiland-Jäggi. “Building up distributorships worldwide is very time consuming with respect to finding interested partners and identifying the best distributor. It demands many phone calls or emails and plenty of travelling time”.



Another example of a satisfied Bridge4Bio customer is a mid-sized, privately owned company - SERVA Electrophoresis GmbH.  The company is based in Heidelberg, Germany and was founded in 1953 with the mission to fulfill the ever growing demand for high quality reagents required by life scientists. SERVA provides innovative products for molecular and cell biology and protein analytics including electrophoresis to life scientists worldwide - through its distribution partners and also directly to end-users.



“SERVA’s strategy is to grow its internal presence,” explained Barbara Mueller, Managing Director of SERVA Electrophoresis GmbH.  “We chose Bridge4Bio because the Bridge4Bio team offers many years of professional experience in the life science research market, a broad knowledge of customers and technologies in use – the perfect prerequisite to quickly identify new partners for SERVA”.



“As a globally acting networking platform, Bridge4Bio enabled us to quickly enhance our international presence by adding new distribution partners, worldwide. They have done a great job in identifying high value partners and have added revenues to SERVA after short period of time”.



Mueller continued: “The greatest savings in time and capacity achieved by the Bridge4Bio service have been the screening and identification of new distribution partners with a clear return of investment”.



Bridge4Bio will be exhibiting on stand number A3-380 at Analytica 2010, March 23 -26, 2010 Munich, Germany.

# # #

Phoenix MarCom is a specialist marketing communications company, delivering a full range of research, design,
planning and management services for literature, advertising, press and public relations, the internet, exhibitions and
conferences.